Richard Garfein

Title(s)Professor, Herbert Wertheim School of Public Health & Human Longevity Science
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California Santa Barbara, Santa Barbara, CABA1985Biology
    San Diego State University, School of Public Health, San Diego, CAMPH1989Epidemiology
    Johns Hopkins University, School of Hygiene and Public Health, Baltimore, MDPhD1997Infectious Diease Epidemiology

    Collapse Research 
    Collapse Research Activities and Funding
    Cell Phone Video Directly Observed Therapy to Monitor Short Course LTBI Treatment
    NIH U01AI116392Mar 16, 2015 - Feb 28, 2021
    Role: Principal Investigator
    Drug tourism to Mexico: Impact of Mexicos new drug law on HIV-HCV-TB in US IDUs
    NIH R01DA031074Aug 1, 2011 - May 31, 2016
    Role: Principal Investigator
    Mobile Phone-Based Video Directly Observed Therapy for Tuberculosis
    NIH R21AI088326Apr 1, 2010 - Mar 31, 2013
    Role: Principal Investigator
    Cross-Border Dynamics of MDR/XDR-TB Epidemiology by HIV Status in Tijuana, Mexico
    NIH R56AI081321Sep 27, 2009 - Aug 31, 2011
    Role: Principal Investigator
    Reducing Sexual HIV Risk among Methamphetamine-Using MSM in San Diego, CA
    NIH UR6PS000306Sep 30, 2006 - Sep 29, 2009
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Featured Content 
    Collapse Featured Videos

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Genomic surveillance reveals dynamic shifts in the connectivity of COVID-19 epidemics. Cell. 2023 12 21; 186(26):5690-5704.e20. Matteson NL, Hassler GW, Kurzban E, Schwab MA, Perkins SA, Gangavarapu K, Levy JI, Parker E, Pride D, Hakim A, De Hoff P, Cheung W, Castro-Martinez A, Rivera A, Veder A, Rivera A, Wauer C, Holmes J, Wilson J, Ngo SN, Plascencia A, Lawrence ES, Smoot EW, Eisner ER, Tsai R, Chacón M, Baer NA, Seaver P, Salido RA, Aigner S, Ngo TT, Barber T, Ostrander T, Fielding-Miller R, Simmons EH, Zazueta OE, Serafin-Higuera I, Sanchez-Alavez M, Moreno-Camacho JL, García-Gil A, Murphy Schafer AR, McDonald E, Corrigan J, Malone JD, Stous S, Shah S, Moshiri N, Weiss A, Anderson C, Aceves CM, Spencer EG, Hufbauer EC, Lee JJ, King AJ, Ramesh KS, Nguyen KN, Saucedo K, Robles-Sikisaka R, Fisch KM, Gonias SL, Birmingham A, McDonald D, Karthikeyan S, Martin NK, Schooley RT, Negrete AJ, Reyna HJ, Chavez JR, Garcia ML, Cornejo-Bravo JM, Becker D, Isaksson M, Washington NL, Lee W, Garfein RS, Luna-Ruiz Esparza MA, Alcántar-Fernández J, Henson B, Jepsen K, Olivares-Flores B, Barrera-Badillo G, Lopez-Martínez I, Ramírez-González JE, Flores-León R, Kingsmore SF, Sanders A, Pradenas A, White B, Matthews G, Hale M, McLawhon RW, Reed SL, Winbush T, McHardy IH, Fielding RA, Nicholson L, Quigley MM, Harding A, Mendoza A, Bakhtar O, Browne SH, Olivas Flores J, Rincon Rodríguez DG, Gonzalez Ibarra M, Robles Ibarra LC, Arellano Vera BJ, Gonzalez Garcia J, Harvey-Vera A, Knight R, Laurent LC, Yeo GW, Wertheim JO, Ji X, Worobey M, Suchard MA, Andersen KG, Campos-Romero A, Wohl S, Zeller M. PMID: 38101407; PMCID: PMC10795731.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsPHPublic Health
    2. Breastfeeding and neurodevelopment in infants with prenatal alcohol exposure. Pediatr Res. 2023 Oct 16. Schaffer KE, Chambers CD, Garfein RS, Wertelecki W, Bandoli G. PMID: 37845525.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Unit costs of needle and syringe program provision: a global systematic review and cost extrapolation. AIDS. 2023 12 01; 37(15):2389-2397. Killion JA, Magana C, Cepeda JA, Vo A, Hernandez M, Cyr CL, Heskett KM, Wilson DP, Graff Zivin J, Zúñiga ML, Pines HA, Garfein RS, Vickerman P, Terris-Prestholt F, Wynn A, Martin NK. PMID: 37773035; PMCID: PMC10653296.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    4. Association between where men who have sex with men (MSM) meet sexual partners and chlamydia/gonorrhoea infection before and during the COVID-19 pandemic in San Diego, California. Sex Transm Infect. 2023 12; 99(8):527-533. King CMB, Garfein RS, Bazzi AR, Little SJ, Skaathun B. PMID: 37402567; PMCID: PMC10764637.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsPHPublic Health
    5. Hepatitis C Virus Micro-elimination Among People With HIV in San Diego: Are We on Track? Open Forum Infect Dis. 2023 Apr; 10(4):ofad153. Cheema JS, Mathews WC, Wynn A, Bamford LB, Torriani FJ, Hill LA, Rajagopal AV, Yin J, Jain S, Garfein RS, Cachay ER, Martin NK. PMID: 37065984; PMCID: PMC10099471.
      View in: PubMed   Mentions:
    6. Challenges of COVID-19 Case Investigation and Contact Tracing in School Settings: An Initial Investigation. J Sch Health. 2023 05; 93(5):353-359. Vo AV, Majnoonian A, Ni J, Garfein RS, Wishard Guerra A, Fielding-Miller R. PMID: 36938803; PMCID: PMC10484113.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    7. "It's hard for everyone" systemic barriers to home confinement to prevent community spread of COVID-19. Transl Behav Med. 2023 02 28; 13(2):64-72. Omaleki V, Vo AV, Flores M, Majnoonian A, Le T, Nguyen M, Duong D, Hassani A, Wijaya FC, Gonzalez-Zuniga PE, Gaines T, Garfein RS, Fielding-Miller R. PMID: 36271869; PMCID: PMC9620324.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansPHPublic Health
    8. Safer at school early alert: an observational study of wastewater and surface monitoring to detect COVID-19 in elementary schools. Lancet Reg Health Am. 2023 Mar; 19:100449. Fielding-Miller R, Karthikeyan S, Gaines T, Garfein RS, Salido RA, Cantu VJ, Kohn L, Martin NK, Wynn A, Wijaya C, Flores M, Omaleki V, Majnoonian A, Gonzalez-Zuniga P, Nguyen M, Vo AV, Le T, Duong D, Hassani A, Tweeten S, Jepsen K, Henson B, Hakim A, Birmingham A, De Hoff P, Mark AM, Nasamran CA, Rosenthal SB, Moshiri N, Fisch KM, Humphrey G, Farmer S, Tubb HM, Valles T, Morris J, Kang J, Khaleghi B, Young C, Akel AD, Eilert S, Eno J, Curewitz K, Laurent LC, Rosing T, Knight R, SEARCH. PMID: 36844610; PMCID: PMC9939935.
      View in: PubMed   Mentions: 14  
    9. Wastewater and surface monitoring to detect COVID-19 in elementary school settings: The Safer at School Early Alert project. medRxiv. 2023 Jan 25. Fielding-Miller R, Karthikeyan S, Gaines T, Garfein RS, Salido RA, Cantu VJ, Kohn L, Martin NK, Wynn A, Wijaya C, Flores M, Omaleki V, Majnoonian A, Gonzalez-Zuniga P, Nguyen M, Vo AV, Le T, Duong D, Hassani A, Tweeten S, Jepsen K, Henson B, Hakim A, Birmingham A, De Hoff P, Mark AM, Nasamran CA, Rosenthal SB, Moshiri N, Fisch KM, Humphrey G, Farmer S, Tubb HM, Valles T, Morris J, Kang J, Khaleghi B, Young C, Akel AD, Eilert S, Eno J, Curewitz K, Laurent LC, Rosing T, Knight R. PMID: 34704096; PMCID: PMC8547528.
      View in: PubMed   Mentions: 1  
    10. COVID-19 disproportionately impacts access to basic needs among households with disabled members. Disabil Health J. 2023 04; 16(2):101443. Streuli S, Garfein RS, Gaines T, Fielding-Miller R. PMID: 36764843; PMCID: PMC9851949.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    11. Knowledge, Attitude, Practices, and Vaccine Hesitancy Among the Latinx Community in Southern California Early in the COVID-19 Pandemic: Cross-sectional Survey. JMIR Form Res. 2022 Aug 04; 6(8):e38351. Mehta SN, Burger ZC, Meyers-Pantele SA, Garfein RS, Ortiz DO, Mudhar PK, Kothari SB, Kothari J, Meka M, Rodwell T. PMID: 35925649; PMCID: PMC9359308.
      View in: PubMed   Mentions: 1  
    12. Prevalence of SARS-CoV-2 infection in Baja California, Mexico: Findings from a community-based survey in February 2021 in the Mexico-United States border. PLOS Glob Public Health. 2022; 2(8):e0000820. Zazueta OE, Garfein RS, Cano-Torres JO, Méndez-Lizárraga CA, Rodwell TC, Muñiz-Salazar R, Ovalle-Marroquín DF, Yee NG, Serafín-Higuera IR, González-Reyes S, Machado-Contreras JR, Horton LE, Strathdee SA, Rodríguez R, Hill L, Bojórquez-Chapela I. PMID: 36962566; PMCID: PMC10021449.
      View in: PubMed   Mentions: 1  
    13. Impact of COVID-19 on tuberculosis detection and treatment in Baja California, México. Front Public Health. 2022; 10:921596. Muñiz-Salazar R, Le T, Cuevas-Mota J, González-Fagoaga JE, Zapata-Garibay R, Ruiz-Tamayo PS, Robles-Flores J, Garfein RS. PMID: 35942259; PMCID: PMC9356343.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    14. Wastewater sequencing reveals early cryptic SARS-CoV-2 variant transmission. Nature. 2022 09; 609(7925):101-108. Karthikeyan S, Levy JI, De Hoff P, Humphrey G, Birmingham A, Jepsen K, Farmer S, Tubb HM, Valles T, Tribelhorn CE, Tsai R, Aigner S, Sathe S, Moshiri N, Henson B, Mark AM, Hakim A, Baer NA, Barber T, Belda-Ferre P, Chacón M, Cheung W, Cresini ES, Eisner ER, Lastrella AL, Lawrence ES, Marotz CA, Ngo TT, Ostrander T, Plascencia A, Salido RA, Seaver P, Smoot EW, McDonald D, Neuhard RM, Scioscia AL, Satterlund AM, Simmons EH, Abelman DB, Brenner D, Bruner JC, Buckley A, Ellison M, Gattas J, Gonias SL, Hale M, Hawkins F, Ikeda L, Jhaveri H, Johnson T, Kellen V, Kremer B, Matthews G, McLawhon RW, Ouillet P, Park D, Pradenas A, Reed S, Riggs L, Sanders A, Sollenberger B, Song A, White B, Winbush T, Aceves CM, Anderson C, Gangavarapu K, Hufbauer E, Kurzban E, Lee J, Matteson NL, Parker E, Perkins SA, Ramesh KS, Robles-Sikisaka R, Schwab MA, Spencer E, Wohl S, Nicholson L, McHardy IH, Dimmock DP, Hobbs CA, Bakhtar O, Harding A, Mendoza A, Bolze A, Becker D, Cirulli ET, Isaksson M, Schiabor Barrett KM, Washington NL, Malone JD, Schafer AM, Gurfield N, Stous S, Fielding-Miller R, Garfein RS, Gaines T, Anderson C, Martin NK, Schooley R, Austin B, MacCannell DR, Kingsmore SF, Lee W, Shah S, McDonald E, Yu AT, Zeller M, Fisch KM, Longhurst C, Maysent P, Pride D, Khosla PK, Laurent LC, Yeo GW, Andersen KG, Knight R. PMID: 35798029; PMCID: PMC9433318.
      View in: PubMed   Mentions: 105     Fields:    Translation:HumansCellsPHPublic Health
    15. Impact of SHIELD Police Training on Knowledge of Syringe Possession Laws and Related Arrests in Tijuana, Mexico. Am J Public Health. 2022 06; 112(6):860-864. Baker P, Beletsky L, Garfein R, Pitpitan E, Oren E, Strathdee SA, Cepeda JA. PMID: 35446602; PMCID: PMC9137025.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    16. Wastewater sequencing uncovers early, cryptic SARS-CoV-2 variant transmission. medRxiv. 2022 Apr 04. Karthikeyan S, Levy JI, De Hoff P, Humphrey G, Birmingham A, Jepsen K, Farmer S, Tubb HM, Valles T, Tribelhorn CE, Tsai R, Aigner S, Sathe S, Moshiri N, Henson B, Mark AM, Hakim A, Baer NA, Barber T, Belda-Ferre P, Chacón M, Cheung W, Cresini ES, Eisner ER, Lastrella AL, Lawrence ES, Marotz CA, Ngo TT, Ostrander T, Plascencia A, Salido RA, Seaver P, Smoot EW, McDonald D, Neuhard RM, Scioscia AL, Satterlund AM, Simmons EH, Abelman DB, Brenner D, Bruner JC, Buckley A, Ellison M, Gattas J, Gonias SL, Hale M, Hawkins F, Ikeda L, Jhaveri H, Johnson T, Kellen V, Kremer B, Matthews G, McLawhon RW, Ouillet P, Park D, Pradenas A, Reed S, Riggs L, Sanders A, Sollenberger B, Song A, White B, Winbush T, Aceves CM, Anderson C, Gangavarapu K, Hufbauer E, Kurzban E, Lee J, Matteson NL, Parker E, Perkins SA, Ramesh KS, Robles-Sikisaka R, Schwab MA, Spencer E, Wohl S, Nicholson L, Mchardy IH, Dimmock DP, Hobbs CA, Bakhtar O, Harding A, Mendoza A, Bolze A, Becker D, Cirulli ET, Isaksson M, Barrett KMS, Washington NL, Malone JD, Schafer AM, Gurfield N, Stous S, Fielding-Miller R, Garfein RS, Gaines T, Anderson C, Martin NK, Schooley R, Austin B, MacCannell DR, Kingsmore SF, Lee W, Shah S, McDonald E, Yu AT, Zeller M, Fisch KM, Longhurst C, Maysent P, Pride D, Khosla PK, Laurent LC, Yeo GW, Andersen KG, Knight R. PMID: 35411350; PMCID: PMC8996633.
      View in: PubMed   Mentions:
    17. The impact of the COVID-19 pandemic among migrants in shelters in Tijuana, Baja California, Mexico. BMJ Glob Health. 2022 03; 7(3). Bojorquez-Chapela I, Strathdee SA, Garfein RS, Benson CA, Chaillon A, Ignacio C, Sepulveda J. PMID: 35277428; PMCID: PMC8919131.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCellsPHPublic Health
    18. Discordant results of tests for tuberculosis reconsidered - Authors' reply. Lancet Infect Dis. 2022 02; 22(2):164-165. Ho CS, Feng PJ, Narita M, Stout JE, Chen M, Pascopella L, Garfein R, Reves R, Katz DJ, Tuberculosis Epidemiologic Studies Consortium. PMID: 35092787.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    19. Optimal Testing Choice and Diagnostic Strategies for Latent Tuberculosis Infection Among US-Born People Living with Human Immunodeficiency Virus (HIV). Clin Infect Dis. 2021 10 05; 73(7):e2278-e2284. Pettit AC, Stout JE, Belknap R, Benson CA, Séraphin MN, Lauzardo M, Horne DJ, Garfein RS, Maruri F, Ho CS, Tuberculosis Epidemiologic Studies Consortium (TBESC). PMID: 32761083; PMCID: PMC8678585.
      View in: PubMed   Mentions: 5     Fields:    
    20. Comparison of three tests for latent tuberculosis infection in high-risk people in the USA: an observational cohort study. Lancet Infect Dis. 2022 01; 22(1):85-96. Ho CS, Feng PI, Narita M, Stout JE, Chen M, Pascopella L, Garfein R, Reves R, Katz DJ, Tuberculosis Epidemiologic Studies Consortium. PMID: 34499863; PMCID: PMC8712384.
      View in: PubMed   Mentions: 13     Fields:    
    21. Involvement of people who inject drugs in injection initiation events: a cross-sectional analysis identifying similarities and differences across three North American settings. BMJ Open. 2021 08 12; 11(8):e046957. Marks C, Meyers SA, Jain S, Sun X, Hayashi K, Gonzalez-Zuniga P, Strathdee SA, Garfein RS, Milloy MJ, DeBeck K, Cummins K, Werb D. PMID: 34385244; PMCID: PMC8362731.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    22. Municipal police support for harm reduction services in officer-led referrals of people who inject drugs in Tijuana, Mexico. Harm Reduct J. 2021 07 26; 18(1):76. Baker P, Arredondo J, Borquez A, Clairgue E, Mittal ML, Morales M, Rocha-Jimenez T, Garfein R, Oren E, Pitpitan E, Strathdee SA, Beletsky L, Cepeda JA. PMID: 34311765; PMCID: PMC8313001.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    23. Cost-effectiveness of hepatitis C virus (HCV) elimination strategies among people who inject drugs (PWID) in Tijuana, Mexico. Addiction. 2021 10; 116(10):2734-2745. Marquez LK, Fleiz C, Burgos JL, Cepeda JA, McIntosh C, Garfein RS, Kiene SM, Brodine S, Strathdee SA, Martin NK. PMID: 33620750; PMCID: PMC8380744.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    24. Cost and cost-effectiveness of a real-world HCV treatment program among HIV-infected individuals in Myanmar. BMJ Glob Health. 2021 02; 6(2). Marquez LK, Chaillon A, Soe KP, Johnson DC, Zosso JM, Incerti A, Loarec A, Nguyen A, Walker JG, Mafirakureva N, Lo Re Iii V, Wynn A, McIntosh C, Kiene SM, Brodine S, Garfein RS, Vickerman P, Martin NK. PMID: 33627360; PMCID: PMC7908309.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    25. Identifying COVID-19 Cases and Social Groups at High Risk of Transmission: A Strategy to Reduce Community Spread. Public Health Rep. 2021 05; 136(3):259-263. Gunn RA, Bellettiere J, Garfein RS, Long KC, Binkin NJ, Anderson CAM. PMID: 33508206; PMCID: PMC8580387.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsPHPublic Health
    26. Latent Tuberculosis Screening Using Electronic Health Record Data. Emerg Infect Dis. 2020 09; 26(9):2285-2287. Jenks JD, Garfein RS, Zhu W, Hogarth M. PMID: 32818426; PMCID: PMC7454063.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    27. Self-perception of assisting with future injection drug initiation: The influence of relationships in the process of drug injecting initiation. Drug Alcohol Rev. 2021 01; 40(1):109-117. Bloom BE, Jain S, Sun X, Garfein RS, Strathdee SA, Milloy MJ, Hayashi K, DeBeck K, Bluthenthal R, Werb D, Rafful C. PMID: 32840027; PMCID: PMC7977721.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    28. Prevalence and correlates of obstructive lung disease among people who inject drugs, San Diego, California. Drug Alcohol Depend. 2020 09 01; 214:108158. Koslik HJ, Joshua J, Cuevas-Mota J, Goba D, Oren E, Alcaraz JE, Garfein RS. PMID: 32652379; PMCID: PMC7331511.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    29. Evaluation of recorded video-observed therapy for anti-tuberculosis treatment. Int J Tuberc Lung Dis. 2020 05 01; 24(5):520-525. Garfein RS, Liu L, Cuevas-Mota J, Collins K, Catanzaro DG, Muñoz F, Moser K, Chuck C, Higashi J, Bulterys MA, Raab F, Rios P. PMID: 32398202.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    30. Video directly observed therapy for supporting and monitoring adherence to tuberculosis treatment in Uganda: a pilot cohort study. ERJ Open Res. 2020 Jan; 6(1). Sekandi JN, Buregyeya E, Zalwango S, Dobbin KK, Atuyambe L, Nakkonde D, Turinawe J, Tucker EG, Olowookere S, Turyahabwe S, Garfein RS. PMID: 32280670; PMCID: PMC7132038.
      View in: PubMed   Mentions: 18  
    31. Is hepatitis C virus (HCV) elimination achievable among people who inject drugs in Tijuana, Mexico? A modeling analysis. Int J Drug Policy. 2021 02; 88:102710. Marquez LK, Cepeda JA, Bórquez A, Strathdee SA, Gonzalez-Zúñiga PE, Fleiz C, Rafful C, Garfein RS, Kiene SM, Brodine S, Martin NK. PMID: 32165050; PMCID: PMC8133359.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    32. Requiring smartphone ownership for mHealth interventions: who could be left out? BMC Public Health. 2020 Jan 20; 20(1):81. Bommakanti KK, Smith LL, Liu L, Do D, Cuevas-Mota J, Collins K, Munoz F, Rodwell TC, Garfein RS. PMID: 31959145; PMCID: PMC6971938.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    33. Prevalence and Correlates of Injecting with Visitors from the United States Among People Who Inject Drugs in Tijuana, Mexico. J Immigr Minor Health. 2019 Dec; 21(6):1200-1207. Bórquez A, Garfein RS, Abramovitz D, Liu L, Beletsky L, Werb D, Mehta SR, Rangel G, Magis-Rodríguez C, González-Zúñiga P, Strathdee SA. PMID: 30771144; PMCID: PMC6697237.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    34. Opioid agonist treatment scale-up and the initiation of injection drug use: A dynamic modeling analysis. PLoS Med. 2019 11; 16(11):e1002973. Marks C, Borquez A, Jain S, Sun X, Strathdee SA, Garfein RS, Milloy MJ, DeBeck K, Cepeda JA, Werb D, Martin NK. PMID: 31770373; PMCID: PMC6879119.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    35. The role of gender and power dynamics in injection initiation events within intimate partnerships in the US-Mexico border region. Cult Health Sex. 2020 09; 22(9):1080-1095. Meyers SA, Smith LR, Luisa Mittal M, Strathdee SA, Garfein RS, Guise A, Werb D, Rafful C. PMID: 31625809; PMCID: PMC7771651.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    36. Primary Incidence of Hepatitis C Virus Infection Among HIV-Infected Men Who Have Sex With Men in San Diego, 2000-2015. Open Forum Infect Dis. 2019 Apr; 6(4):ofz160. Chaillon A, Sun X, Cachay ER, Looney D, Wyles D, Garfein RS, Martin TCS, Martin TCS, Jain S, Mehta SR, Smith DM, Little SJ, Martin NK. PMID: 31041355; PMCID: PMC6483132.
      View in: PubMed   Mentions: 16  
    37. Synchronous and asynchronous video observed therapy (VOT) for tuberculosis treatment adherence monitoring and support. J Clin Tuberc Other Mycobact Dis. 2019 Dec; 17:100098. Garfein RS, Doshi RP. PMID: 31867442; PMCID: PMC6904830.
      View in: PubMed   Mentions: 20  
    38. Association of Self-Reported Abscess With High-Risk Injection-Related Behaviors Among Young Persons Who Inject Drugs. J Assoc Nurses AIDS Care. 2019 Mar-Apr; 30(2):142-150. Asher AK, Zhong Y, Garfein RS, Cuevas-Mota J, Teshale E. PMID: 30822287.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    39. Smartphone-enabled video-observed versus directly observed treatment for tuberculosis: a multicentre, analyst-blinded, randomised, controlled superiority trial. Lancet. 2019 Mar 23; 393(10177):1216-1224. Story A, Aldridge RW, Smith CM, Garber E, Hall J, Ferenando G, Possas L, Hemming S, Wurie F, Luchenski S, Abubakar I, McHugh TD, White PJ, Watson JM, Lipman M, Garfein R, Hayward AC. PMID: 30799062; PMCID: PMC6429626.
      View in: PubMed   Mentions: 78     Fields:    Translation:Humans
    40. Change in Patient Comfort Using Mobile Phones Following the Use of an App to Monitor Tuberculosis Treatment Adherence: Longitudinal Study. JMIR Mhealth Uhealth. 2019 02 01; 7(2):e11638. Do D, Garfein RS, Cuevas-Mota J, Collins K, Liu L. PMID: 30707103; PMCID: PMC6376328.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    41. Prevalence and correlates of diabetes and metabolic syndrome in a rural indigenous community in Baja California, Mexico. BMC Public Health. 2018 Dec 20; 18(1):1397. Pacheco LS, Hernández-Ontiveros DA, Iniguez-Stevens E, Brodine S, Garfein RS, Santibañez M, Fraga MA. PMID: 30572860; PMCID: PMC6302508.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    42. Identification of a Syndemic of Blood-Borne Disease Transmission and Injection Drug Use Initiation at the US-Mexico Border. J Acquir Immune Defic Syndr. 2018 12 15; 79(5):559-565. Rafful C, Jain S, Sun X, Strathdee SA, Garfein RS, Cuevas-Mota J, Magis-Rodríguez C, Smith LR, Werb D. PMID: 30222661; PMCID: PMC6231973.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansPHPublic Health
    43. Gender differences in the provision of injection initiation assistance: a comparison of three North American settings. Harm Reduct J. 2018 12 04; 15(1):59. Meyers SA, Scheim A, Jain S, Sun X, Milloy MJ, DeBeck K, Hayashi K, Garfein RS, Werb D. PMID: 30514384; PMCID: PMC6280353.
      View in: PubMed   Mentions: 14     Fields:    
    44. Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis. Lancet Infect Dis. 2018 12; 18(12):1397-1409. Stone J, Fraser H, Lim AG, Walker JG, Ward Z, MacGregor L, Trickey A, Abbott S, Strathdee SA, Abramovitz D, Maher L, Iversen J, Bruneau J, Zang G, Garfein RS, Yen YF, Azim T, Mehta SH, Milloy MJ, Hellard ME, Sacks-Davis R, Dietze PM, Aitken C, Aladashvili M, Tsertsvadze T, Mravcík V, Alary M, Roy E, Smyrnov P, Sazonova Y, Young AM, Havens JR, Hope VD, Desai M, Heinsbroek E, Hutchinson SJ, Palmateer NE, McAuley A, Platt L, Martin NK, Altice FL, Hickman M, Vickerman P. PMID: 30385157; PMCID: PMC6280039.
      View in: PubMed   Mentions: 87     Fields:    Translation:HumansPHPublic Health
    45. Tuberculosis Treatment Monitoring by Video Directly Observed Therapy in 5 Health Districts, California, USA. Emerg Infect Dis. 2018 10; 24(10):1806-1815. Garfein RS, Liu L, Cuevas-Mota J, Collins K, Muñoz F, Catanzaro DG, Moser K, Higashi J, Al-Samarrai T, Kriner P, Vaishampayan J, Cepeda J, Bulterys MA, Martin NK, Rios P, Raab F. PMID: 30226154; PMCID: PMC6154139.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCTClinical Trials
    46. A fragmented code: The moral and structural context for providing assistance with injection drug use initiation in San Diego, USA. Int J Drug Policy. 2018 05; 55:51-60. Guise A, Melo J, Mittal ML, Rafful C, Cuevas-Mota J, Davidson P, Garfein RS, Werb D. PMID: 29524733; PMCID: PMC5970953.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    47. Cost analysis of rapid diagnostics for drug-resistant tuberculosis. BMC Infect Dis. 2018 03 02; 18(1):102. Groessl EJ, Ganiats TG, Hillery N, Trollip A, Jackson RL, Catanzaro DG, Rodwell TC, Garfein RS, Rodrigues C, Crudu V, Victor TC, Catanzaro A. PMID: 29499645; PMCID: PMC5833048.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    48. Individual and community factors contributing to anemia among women in rural Baja California, Mexico. PLoS One. 2017; 12(11):e0188590. Moor MA, Fraga MA, Garfein RS, Rashidi HH, Alcaraz J, Kritz-Silverstein D, Elder JP, Brodine SK. PMID: 29176817; PMCID: PMC5703514.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    49. Do law enforcement interactions reduce the initiation of injection drug use? An investigation in three North American settings. Drug Alcohol Depend. 2018 01 01; 182:67-73. Melo JS, Garfein RS, Hayashi K, Milloy MJ, DeBeck K, Sun S, Jain S, Strathdee SA, Werb D. PMID: 29169035; PMCID: PMC6219752.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    50. Potential benefits of using ecological momentary assessment to study high-risk polydrug use. Mhealth. 2017; 3:46. Roth AM, Felsher M, Reed M, Goldshear JL, Truong Q, Garfein RS, Simmons J. PMID: 29184898; PMCID: PMC5682359.
      View in: PubMed   Mentions: 12  
    51. History of medication-assisted treatment and its association with initiating others into injection drug use in San Diego, CA. Subst Abuse Treat Prev Policy. 2017 10 03; 12(1):42. Mittal ML, Vashishtha D, Sun S, Jain S, Cuevas-Mota J, Garfein R, Strathdee SA, Werb D. PMID: 28974239; PMCID: PMC5627474.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    52. Impact of Fluoroquinolone Use on Mortality Among a Cohort of Patients With Suspected Drug-Resistant Tuberculosis. Clin Infect Dis. 2017 Sep 01; 65(5):772-778. Seifert M, Georghiou SB, Garfein RS, Catanzaro D, Rodwell TC. PMID: 28475735; PMCID: PMC5848235.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    53. Comparison of Three Popular Methods for Recruiting Young Persons Who Inject Drugs for Interventional Studies. J Urban Health. 2017 08; 94(4):587-591. Collier MG, Garfein RS, Cuevas-Mota J, Teshale EH. PMID: 28488087; PMCID: PMC5533661.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    54. Cross-border injection drug use and HIV and hepatitis C virus seropositivity among people who inject drugs in San Diego, California. Int J Drug Policy. 2017 09; 47:9-17. Horyniak D, Wagner KD, Armenta RF, Cuevas-Mota J, Hendrickson E, Garfein RS. PMID: 28683432; PMCID: PMC5592143.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    55. Cold Preparation of Heroin in a Black Tar Market. Subst Use Misuse. 2017 07 29; 52(9):1202-1206. Roth AM, Armenta RF, Wagner KD, Strathdee SA, Goldshear JL, Cuevas-Mota J, Garfein RS. PMID: 28605301; PMCID: PMC6125133.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    56. Increased Tuberculosis Patient Mortality Associated with Mycobacterium tuberculosis Mutations Conferring Resistance to Second-Line Antituberculous Drugs. J Clin Microbiol. 2017 06; 55(6):1928-1937. Georghiou SB, Seifert M, Catanzaro DG, Garfein RS, Rodwell TC. PMID: 28404672; PMCID: PMC5442550.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    57. Evaluation of the microscopic observation drug susceptibility assay for the detection of first- and second-line drug susceptibility for Mycobacterium tuberculosis. Eur Respir J. 2017 04; 49(4). Catanzaro DG, Trollip AP, Seifert M, Georghiou SB, Garfein RS, Rodwell TC, Catanzaro A, Eisenach KD. PMID: 28381434; PMCID: PMC6141189.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    58. Mycobacterium tuberculosis infection among persons who inject drugs in San Diego, California. Int J Tuberc Lung Dis. 2017 04 01; 21(4):425-431. Armenta RF, Collins KM, Strathdee SA, Bulterys MA, Munoz F, Cuevas-Mota J, Chiles P, Garfein RS. PMID: 28284258; PMCID: PMC6352726.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    59. Potential Risks of Ecological Momentary Assessment Among Persons Who Inject Drugs. Subst Use Misuse. 2017 06 07; 52(7):840-847. Roth AM, Rossi J, Goldshear JL, Truong Q, Armenta RF, Lankenau SE, Garfein RS, Simmons J. PMID: 28426353; PMCID: PMC9540984.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    60. Differential experiences of Mexican policing by people who inject drugs residing in Tijuana and San Diego. Int J Drug Policy. 2017 03; 41:132-139. Wood EF, Werb D, Beletsky L, Rangel G, Cuevas Mota J, Garfein RS, Strathdee SA, Wagner KD. PMID: 28111221; PMCID: PMC5342893.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    61. Mobility patterns of persons at risk for drug-resistant tuberculosis in Mumbai, India. Int J Tuberc Lung Dis. 2016 12; 20(12):1633-1638. Conners E, Garfein RS, Rodwell TC, Udwadia ZF, Catanzaro DG. PMID: 27931339; PMCID: PMC10424886.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    62. Concurrency and HIV transmission network characteristics among MSM with recent HIV infection. AIDS. 2016 11 28; 30(18):2875-2883. Pines HA, Wertheim JO, Liu L, Garfein RS, Little SJ, Karris MY. PMID: 27662550; PMCID: PMC5279958.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCellsPHPublic Health
    63. Surveillance or support: The experience of direct observation during tuberculosis treatment. Glob Public Health. 2018 07; 13(7):804-818. Bojorquez I, Salazar I, Garfein RS, Cerecer P, Rodwell TC. PMID: 27748157; PMCID: PMC5392434.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    64. A socio-structural approach to preventing injection drug use initiation: rationale for the PRIMER study. Harm Reduct J. 2016 09 15; 13(1):25. Werb D, Garfein R, Kerr T, Davidson P, Roux P, Jauffret-Roustide M, Auriacombe M, Small W, Strathdee SA. PMID: 27629248; PMCID: PMC5024479.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    65. Prevalence and Correlates of Heroin-Methamphetamine Co-Injection Among Persons Who Inject Drugs in San Diego, California, and Tijuana, Baja California, Mexico. J Stud Alcohol Drugs. 2016 09; 77(5):774-81. Meacham MC, Strathdee SA, Rangel G, Armenta RF, Gaines TL, Garfein RS. PMID: 27588536; PMCID: PMC5015469.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    66. Shedding light on the performance of a pyrosequencing assay for drug-resistant tuberculosis diagnosis. BMC Infect Dis. 2016 08 31; 16:458. Georghiou SB, Seifert M, Lin SY, Catanzaro D, Garfein RS, Jackson RL, Crudu V, Rodrigues C, Victor TC, Catanzaro A, Rodwell TC. PMID: 27576542; PMCID: PMC5006534.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    67. Decreased Anemia Prevalence Among Women and Children in Rural Baja California, Mexico: A 6-Year Comparative Study. J Community Health. 2016 08; 41(4):780-9. Moor MA, Fraga MA, Garfein RS, Harbertson J, Rodriguez-Lainz A, Rashidi HH, Elder JP, Brodine SK. PMID: 26856732.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    68. Frequency and Distribution of Tuberculosis Resistance-Associated Mutations between Mumbai, Moldova, and Eastern Cape. Antimicrob Agents Chemother. 2016 07; 60(7):3994-4004. Georghiou SB, Seifert M, Catanzaro D, Garfein RS, Valafar F, Crudu V, Rodrigues C, Victor TC, Catanzaro A, Rodwell TC. PMID: 27090176; PMCID: PMC4914621.
      View in: PubMed   Mentions: 16     Fields:    Translation:Cells
    69. Digital health for the End TB Strategy: developing priority products and making them work. Eur Respir J. 2016 07; 48(1):29-45. Falzon D, Timimi H, Kurosinski P, Migliori GB, Van Gemert W, Denkinger C, Isaacs C, Story A, Garfein RS, do Valle Bastos LG, Yassin MA, Rusovich V, Skrahina A, Van Hoi L, Broger T, Abubakar I, Hayward A, Thomas BV, Temesgen Z, Quraishi S, von Delft D, Jaramillo E, Weyer K, Raviglione MC. PMID: 27230443; PMCID: PMC4929075.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansPHPublic Health
    70. A performance evaluation of MTBDRplus version 2 for the diagnosis of multidrug-resistant tuberculosis. Int J Tuberc Lung Dis. 2016 May; 20(5):631-7. Seifert M, Ajbani K, Georghiou SB, Catanzaro D, Rodrigues C, Crudu V, Victor TC, Garfein RS, Catanzaro A, Rodwell TC. PMID: 27084817; PMCID: PMC4852300.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    71. Factors associated with patterns of mobile technology use among persons who inject drugs. Subst Abus. 2016 Oct-Dec; 37(4):606-612. Collins KM, Armenta RF, Cuevas-Mota J, Liu L, Strathdee SA, Garfein RS. PMID: 27092425; PMCID: PMC5125293.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    72. Monitoring Therapy Compliance of Tuberculosis Patients by using Video-Enabled Electronic Devices. Emerg Infect Dis. 2016 Mar; 22(3):538-40. Story A, Garfein RS, Hayward A, Rusovich V, Dadu A, Soltan V, Oprunenco A, Collins K, Sarin R, Quraishi S, Sharma M, Migliori GB, Varadarajan M, Falzon D. PMID: 26891363; PMCID: PMC4766903.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    73. MTBDRplus and MTBDRsl Assays: Absence of Wild-Type Probe Hybridization and Implications for Detection of Drug-Resistant Tuberculosis. J Clin Microbiol. 2016 Apr; 54(4):912-8. Seifert M, Georghiou SB, Catanzaro D, Rodrigues C, Crudu V, Victor TC, Garfein RS, Catanzaro A, Rodwell TC. PMID: 26763971; PMCID: PMC4809938.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    74. Prevalence and Correlates of the Use of Prefilled Syringes Among Persons Who Inject Drugs in San Diego, CA. J Urban Health. 2015 Dec; 92(6):1081-91. Armenta RF, Roth AM, Wagner KD, Strathdee SA, Brodine SK, Cuevas-Mota J, Munoz FA, Garfein RS. PMID: 26382653; PMCID: PMC4675744.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    75. Feasibility of tuberculosis treatment monitoring by video directly observed therapy: a binational pilot study. Int J Tuberc Lung Dis. 2015 Sep; 19(9):1057-64. Garfein RS, Collins K, Muñoz F, Moser K, Cerecer-Callu P, Raab F, Rios P, Flick A, Zúñiga ML, Cuevas-Mota J, Liang K, Rangel G, Burgos JL, Rodwell TC, Patrick K. PMID: 26260824; PMCID: PMC5673092.
      View in: PubMed   Mentions: 63     Fields:    Translation:Humans
    76. Performance Comparison of Three Rapid Tests for the Diagnosis of Drug-Resistant Tuberculosis. PLoS One. 2015; 10(8):e0136861. Catanzaro A, Rodwell TC, Catanzaro DG, Garfein RS, Jackson RL, Seifert M, Georghiou SB, Trollip A, Groessl E, Hillery N, Crudu V, Victor TC, Rodrigues C, Lin GS, Valafar F, Desmond E, Eisenach K. PMID: 26322781; PMCID: PMC4556461.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    77. HIV Transmission Networks in the San Diego-Tijuana Border Region. EBioMedicine. 2015 Oct; 2(10):1456-63. Mehta SR, Wertheim JO, Brouwer KC, Wagner KD, Chaillon A, Strathdee S, Patterson TL, Rangel MG, Vargas M, Murrell B, Garfein R, Little SJ, Smith DM. PMID: 26629540; PMCID: PMC4634195.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCellsPHPublic Health
    78. Effect of legal status of pharmacy syringe sales on syringe purchases by persons who inject drugs in San Francisco and San Diego, CA. Int J Drug Policy. 2015 Nov; 26(11):1150-7. Siddiqui SS, Armenta RF, Evans JL, Yu M, Cuevas-Mota J, Page K, Davidson P, Garfein RS. PMID: 26252980; PMCID: PMC4581911.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    79. Association between non-fatal opioid overdose and encounters with healthcare and criminal justice systems: Identifying opportunities for intervention. Drug Alcohol Depend. 2015 Aug 01; 153:215-20. Wagner KD, Liu L, Davidson PJ, Cuevas-Mota J, Armenta RF, Garfein RS. PMID: 26091751; PMCID: PMC4512661.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    80. Hepatitis A and B among young persons who inject drugs--vaccination, past, and present infection. Vaccine. 2015 Jun 04; 33(24):2808-12. Collier MG, Drobeniuc J, Cuevas-Mota J, Garfein RS, Kamili S, Teshale EH. PMID: 25889161.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansPHPublic Health
    81. Phenotypic and genotypic diversity in a multinational sample of drug-resistant Mycobacterium tuberculosis isolates. Int J Tuberc Lung Dis. 2015 Apr; 19(4):420-7. Garfein RS, Catanzaro DG, Rodwell TC, Avalos E, Jackson RL, Kaping J, Evasco H, Rodrigues C, Crudu V, Lin SY, Groessl E, Groessel E, Hillery N, Trollip A, Ganiats T, Victor TC, Eisenach K, Valafar F, Channick J, Qian L, Catanzaro A. PMID: 25859997; PMCID: PMC4494864.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    82. Awareness of HCV infection among persons who inject drugs in San Diego, California. Am J Public Health. 2015 Feb; 105(2):302-3. Collier MG, Bhaurla SK, Cuevas-Mota J, Armenta RF, Teshale EH, Garfein RS. PMID: 25521877; PMCID: PMC4318317.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    83. Deportation history among HIV-positive Latinos in two US-Mexico border communities. J Immigr Minor Health. 2015 Feb; 17(1):104-11. Muñoz FA, Servin AE, Garfein RS, Ojeda VD, Rangel G, Zúñiga ML. PMID: 24136247; PMCID: PMC3991765.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    84. Individual and socio-environmental factors associated with unsafe injection practices among young adult injection drug users in San Diego. AIDS Behav. 2015 Jan; 19(1):199-210. Muñoz F, Burgos JL, Cuevas-Mota J, Teshale E, Garfein RS. PMID: 24920342; PMCID: PMC4265001.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    85. Correlates of perceived risk of HIV infection among persons who inject drugs in Tijuana, Baja California, Mexico. Salud Publica Mex. 2015; 57 Suppl 2:s107-12. Armenta RF, Abramovitz D, Lozada R, Vera A, Garfein RS, Magis-Rodríguez C, Strathdee SA. PMID: 26545125; PMCID: PMC5659113.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    86. Feasibility and acceptability of cell phone diaries to measure HIV risk behavior among female sex workers. AIDS Behav. 2014 Dec; 18(12):2314-24. Roth AM, Hensel DJ, Fortenberry JD, Garfein RS, Gunn JK, Wiehe SE. PMID: 24643312; PMCID: PMC4356500.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    87. The Global Consortium for Drug-resistant Tuberculosis Diagnostics (GCDD): design of a multi-site, head-to-head study of three rapid tests to detect extensively drug-resistant tuberculosis. Trials. 2014 Nov 06; 15:434. Hillery N, Groessl EJ, Trollip A, Catanzaro D, Jackson L, Rodwell TC, Garfein RS, Lin SY, Eisenach K, Ganiats TG, Park D, Valafar F, Rodrigues C, Crudu V, Victor TC, Catanzaro A. PMID: 25377177; PMCID: PMC4232628.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCellsCTClinical Trials
    88. Evaluation of pyrosequencing for detecting extensively drug-resistant Mycobacterium tuberculosis among clinical isolates from four high-burden countries. Antimicrob Agents Chemother. 2015 Jan; 59(1):414-20. Ajbani K, Lin SY, Rodrigues C, Nguyen D, Arroyo F, Kaping J, Jackson L, Garfein RS, Catanzaro D, Eisenach K, Victor TC, Crudu V, Gler MT, Ismail N, Desmond E, Catanzaro A, Rodwell TC. PMID: 25367911; PMCID: PMC4291380.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    89. Patterns of drug use, risky behavior, and health status among persons who inject drugs living in San Diego, California: a latent class analysis. Subst Use Misuse. 2015 Jan; 50(2):205-14. Roth AM, Armenta RA, Wagner KD, Roesch SC, Bluthenthal RN, Cuevas-Mota J, Garfein RS. PMID: 25313832; PMCID: PMC4356115.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    90. Use of synthetic cathinones and cannabimimetics among injection drug users in San Diego, California. Drug Alcohol Depend. 2014 Aug 01; 141:99-106. Wagner KD, Armenta RF, Roth AM, Maxwell JC, Cuevas-Mota J, Garfein RS. PMID: 24916748; PMCID: PMC4114932.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    91. The Association between active and passive smoking and latent tuberculosis infection in adults and children in the united states: results from NHANES. PLoS One. 2014; 9(3):e93137. Lindsay RP, Shin SS, Garfein RS, Rusch ML, Novotny TE. PMID: 24664240; PMCID: PMC3963991.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    92. Transitions in latent classes of sexual risk behavior among young injection drug users following HIV prevention intervention. AIDS Behav. 2014 Mar; 18(3):464-72. Mackesy-Amiti ME, Ouellet LJ, Finnegan L, Hagan H, Golub E, Latka M, Wagner K, Garfein RS. PMID: 23975477; PMCID: PMC3932146.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    93. Evaluating the impact of Mexico's drug policy reforms on people who inject drugs in Tijuana, B.C., Mexico, and San Diego, CA, United States: a binational mixed methods research agenda. Harm Reduct J. 2014 Feb 12; 11:4. Robertson AM, Garfein RS, Wagner KD, Mehta SR, Magis-Rodriguez C, Cuevas-Mota J, Moreno-Zuniga PG, Strathdee SA, Proyecto El Cuete IV and STAHR II. PMID: 24520885; PMCID: PMC3944401.
      View in: PubMed   Mentions: 74     Fields:    Translation:Humans
    94. Second-line drug susceptibility breakpoints for Mycobacterium tuberculosis using the MODS assay. Int J Tuberc Lung Dis. 2014 Feb; 18(2):227-32. Trollip AP, Moore D, Coronel J, Caviedes L, Klages S, Victor T, Romancenco E, Crudu V, Ajbani K, Vineet VP, Rodrigues C, Jackson RL, Eisenach K, Garfein RS, Rodwell TC, Desmond E, Groessl EJ, Ganiats TG, Catanzaro A. PMID: 24429318; PMCID: PMC4250530.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    95. Predicting extensively drug-resistant Mycobacterium tuberculosis phenotypes with genetic mutations. J Clin Microbiol. 2014 Mar; 52(3):781-9. Rodwell TC, Valafar F, Douglas J, Qian L, Garfein RS, Chawla A, Torres J, Zadorozhny V, Kim MS, Hoshide M, Catanzaro D, Jackson L, Lin G, Desmond E, Rodrigues C, Eisenach K, Victor TC, Ismail N, Crudu V, Gler MT, Catanzaro A. PMID: 24353002; PMCID: PMC3957771.
      View in: PubMed   Mentions: 57     Fields:    Translation:HumansCells
    96. Dose-response association between salivary cotinine levels and Mycobacterium tuberculosis infection. Int J Tuberc Lung Dis. 2013 Nov; 17(11):1452-8. Shin SS, Laniado-Laborin R, Moreno PG, Novotny TE, Strathdee SA, Garfein RS. PMID: 24125450; PMCID: PMC3801225.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    97. Hepatitis E virus among persons who inject drugs, San Diego, California, USA, 2009-2010. Emerg Infect Dis. 2013 Oct; 19(10):1664-6. Mahajan R, Collier MG, Kamili S, Drobeniuc J, Cuevas-Mota J, Garfein RS, Teshale E. PMID: 24047923; PMCID: PMC3810760.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    98. Cigarette smoking and quit attempts among injection drug users in Tijuana, Mexico. Nicotine Tob Res. 2013 Dec; 15(12):2060-8. Shin SS, Moreno PG, Rao S, Garfein RS, Novotny TE, Strathdee SA. PMID: 23873979; PMCID: PMC3819980.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    99. Peer-education intervention to reduce injection risk behaviors benefits high-risk young injection drug users: a latent transition analysis of the CIDUS 3/DUIT study. AIDS Behav. 2013 Jul; 17(6):2075-83. Mackesy-Amiti ME, Finnegan L, Ouellet LJ, Golub ET, Hagan H, Hudson SM, Latka MH, Garfein RS. PMID: 23142857; PMCID: PMC3672505.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    100. HCV infection prevalence lower than expected among 18-40-year-old injection drug users in San Diego, CA. J Urban Health. 2013 Jun; 90(3):516-28. Garfein RS, Rondinelli A, Barnes RF, Cuevas J, Metzner M, Velasquez M, Rodriguez D, Reilly M, Xing J, Teshale EH. PMID: 22766605; PMCID: PMC3665980.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    101. Multidrug-resistant tuberculosis among patients in Baja California, Mexico, and Hispanic patients in California. Am J Public Health. 2013 Jul; 103(7):1301-5. Bojorquez I, Barnes RF, Flood J, López-Gatell H, Garfein RS, Bäcker CE, Alpuche C, Vinetz JM, Catanzaro A, Kato-Maeda M, Rodwell TC. PMID: 23678924; PMCID: PMC3682598.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    102. Prevalence of diabetes and metabolic syndrome in a migrant Mixtec population, Baja California, Mexico. J Immigr Minor Health. 2013 Feb; 15(1):93-100. Goodman D, Fraga MA, Brodine S, Ibarra MD, Garfein RS. PMID: 22961334; PMCID: PMC4727828.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    103. Tuberculosis, injecting drug use and integrated HIV-TB care: a review of the literature. Drug Alcohol Depend. 2013 May 01; 129(3):180-209. Grenfell P, Baptista Leite R, Garfein R, de Lussigny S, Platt L, Rhodes T. PMID: 23306095.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    104. Cigarette-Smoking Intensity and Interferon-Gamma Release Assay Conversion among Persons Who Inject Drugs: A Cohort Study. Pulm Med. 2012; 2012:828106. Shin SS, Gallardo M, Lozada R, Abramovitz D, Burgos JL, Laniado-Laborin R, Rodwell TC, Novotny TE, Strathdee SA, Garfein RS. PMID: 23304497; PMCID: PMC3529865.
      View in: PubMed   Mentions: 2     Fields:    
    105. Drug-scene familiarity and exposure to gang violence among residents in a rural farming community in Baja California, Mexico. Glob Public Health. 2013; 8(1):65-78. Volkmann T, Fraga MA, Brodine SK, Iñiguez-Stevens E, Cepeda A, Elder JP, Garfein RS, VIIDAI Team. PMID: 23072623; PMCID: PMC3549003.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    106. HIV infection risk among injection drug users in a methadone maintenance treatment program, Taipei, Taiwan 2007-2010. Am J Drug Alcohol Abuse. 2012 Nov; 38(6):544-50. Yen YF, Rodwell TC, Yen MY, Hsu YH, Chuang P, Li LH, Su LW, Yang YH, Jiang XR, Fang YC, Garfein RS. PMID: 22783806; PMCID: PMC4229362.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    107. Tuberculosis testing among populations with high HIV risk in Tijuana, Baja California, Mexico. Rev Panam Salud Publica. 2012 Jul; 32(1):30-5. Velasquez MG, Laniado-Laborin R, Rodwell TC, Cerecer P, Lozada R, Cuevas-Mota J, Burgos JL, Garfein RS. PMID: 22910722; PMCID: PMC3711229.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    108. Field-based performance of three pre-market rapid hepatitis C virus antibody assays in STAHR (Study to Assess Hepatitis C Risk) among young adults who inject drugs in San Diego, CA. J Clin Virol. 2012 Jul; 54(3):213-7. Jewett A, Smith BD, Garfein RS, Cuevas-Mota J, Teshale EH, Weinbaum CM. PMID: 22560051; PMCID: PMC5484575.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    109. Border crossing to inject drugs in Mexico among injection drug users in San Diego, California. J Immigr Minor Health. 2012 Apr; 14(2):281-6. Volkmann T, Shin SS, Garfein RS, Patterson TL, Pollini RA, Wagner KD, Artamanova I, Strathdee SA. PMID: 21442300; PMCID: PMC3163238.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    110. Evaluation of genetic mutations associated with Mycobacterium tuberculosis resistance to amikacin, kanamycin and capreomycin: a systematic review. PLoS One. 2012; 7(3):e33275. Georghiou SB, Magana M, Garfein RS, Catanzaro DG, Catanzaro A, Rodwell TC. PMID: 22479378; PMCID: PMC3315572.
      View in: PubMed   Mentions: 115     Fields:    Translation:HumansCells
    111. Effect of a cash transfer programme for schooling on prevalence of HIV and herpes simplex type 2 in Malawi: a cluster randomised trial. Lancet. 2012 Apr 07; 379(9823):1320-9. Baird SJ, Garfein RS, McIntosh CT, Ozler B. PMID: 22341825.
      View in: PubMed   Mentions: 276     Fields:    Translation:HumansCells
    112. DOT associated with reduced all-cause mortality among tuberculosis patients in Taipei, Taiwan, 2006-2008. Int J Tuberc Lung Dis. 2012 Feb; 16(2):178-84. Yen YF, Rodwell TC, Yen MY, Shih HC, Hu BS, Li LH, Shie YH, Chuang P, Garfein RS. PMID: 22236917; PMCID: PMC3289585.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    113. The social and environmental context of cross-border drug use in Mexico: findings from a mixed methods study of young injection drug users living in San Diego, CA. J Ethn Subst Abuse. 2012; 11(4):362-78. Wagner KD, Moynihan MJ, Strathdee SA, Cuevas-Mota J, Clark M, Zúñiga ML, Volkmann TA, Teshale E, Garfein RS. PMID: 23216441; PMCID: PMC3531810.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    114. High-risk behaviors associated with injection drug use among recently HIV-infected men who have sex with men in San Diego, CA. AIDS Behav. 2011 Oct; 15(7):1561-9. Ghanem A, Little SJ, Drumright L, Liu L, Morris S, Garfein RS. PMID: 21607643; PMCID: PMC4394837.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    115. Problematic use of prescription-type opioids prior to heroin use among young heroin injectors. Subst Abuse Rehabil. 2011 Oct; 2(1):173-180. Pollini RA, Banta-Green CJ, Cuevas-Mota J, Metzner M, Teshale E, Garfein RS. PMID: 23293547; PMCID: PMC3536052.
      View in: PubMed   Mentions: 65  
    116. Latent tuberculosis infection in a migrant agricultural community in Baja California, Mexico. J Immigr Minor Health. 2011 Oct; 13(5):940-7. Garfein RS, Burgos JL, Rodriquez-Lainz A, Brodine S, Pietrucha A, Rondinelli A, Laniado-Laborin R, Ibarra E, Cañez A, Fraga M. PMID: 20669048; PMCID: PMC3155755.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    117. Evaluation of three rapid screening assays for detection of antibodies to hepatitis C virus. J Infect Dis. 2011 Sep 15; 204(6):825-31. Smith BD, Drobeniuc J, Jewett A, Branson BM, Garfein RS, Teshale E, Kamili S, Weinbaum CM. PMID: 21849279.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansPHPublic Health
    118. Trends in mortality of tuberculosis patients in the United States: the long-term perspective. Ann Epidemiol. 2011 Oct; 21(10):791-5. Barnes RF, Moore ML, Garfein RS, Brodine S, Strathdee SA, Rodwell TC. PMID: 21820320; PMCID: PMC3166369.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansPHPublic Health
    119. HIV prevalence and sexual risk behaviour among non-injection drug users in Tijuana, Mexico. Glob Public Health. 2012; 7(2):175-83. Deiss RG, Lozada RM, Burgos JL, Strathdee SA, Gallardo M, Cuevas J, Garfein RS. PMID: 21390967; PMCID: PMC3163240.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    120. Predictors and correlates of reduced frequency or cessation of injection drug use during a randomized HIV prevention intervention trial. Addiction. 2011 Mar; 106(3):601-8. Mackesy-Amiti ME, Ouellet LJ, Golub ET, Hudson S, Hagan H, Garfein RS. PMID: 21182555.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    121. Predictors and effects of alcohol use on liver function among young HCV-infected injection drug users in a behavioral intervention. J Hepatol. 2011 Jul; 55(1):45-52. Drumright LN, Hagan H, Thomas DL, Latka MH, Golub ET, Garfein RS, Clapp JD, Campbell JV, Bonner S, Kapadia F, Thiel TK, Strathdee SA. PMID: 21145862; PMCID: PMC3094600.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    122. Pharmacy participation in non-prescription syringe sales in Los Angeles and San Francisco counties, 2007. J Urban Health. 2010 Jul; 87(4):543-52. Cooper EN, Dodson C, Stopka TJ, Riley ED, Garfein RS, Bluthenthal RN. PMID: 20549568; PMCID: PMC2900565.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    123. Access to sterile syringes through San Francisco pharmacies and the association with HIV risk behavior among injection drug users. J Urban Health. 2010 Jul; 87(4):534-42. Riley ED, Kral AH, Stopka TJ, Garfein RS, Reuckhaus P, Bluthenthal RN. PMID: 20526690; PMCID: PMC2900569.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    124. Evaluating a statewide pilot syringe access program for injection drug users through pharmacies in California. J Urban Health. 2010 Jul; 87(4):531-3. Kral AH, Garfein RS. PMID: 20549567; PMCID: PMC2900576.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    125. Three years after legalization of nonprescription pharmacy syringe sales in California: where are we now? J Urban Health. 2010 Jul; 87(4):576-85. Garfein RS, Stopka TJ, Pavlinac PB, Ross A, Haye BK, Riley ED, Bluthenthal RN. PMID: 20535641; PMCID: PMC2900579.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    126. Evaluation of an HIV nucleic acid testing program with automated Internet and voicemail systems to deliver results. Ann Intern Med. 2010 Jun 15; 152(12):778-85. Morris SR, Little SJ, Cunningham T, Garfein RS, Richman DD, Smith DM. PMID: 20547906; PMCID: PMC2922925.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansPHPublic Health
    127. Formative Assessment of ARM-U: A Modular Intervention for Decreasing Risk Behaviors Among HIV-Positive and HIV-Negative Methamphetamine-Using MSM. Open AIDS J. 2010 May 14; 4:105-15. Garfein RS, Metzner M, Cuevas J, Bousman CA, Patterson T. PMID: 20657829; PMCID: PMC2905777.
      View in: PubMed   Mentions: 7  
    128. Latent tuberculosis among persons at risk for infection with HIV, Tijuana, Mexico. Emerg Infect Dis. 2010 May; 16(5):757-63. Garfein RS, Laniado-Laborin R, Rodwell TC, Lozada R, Deiss R, Burgos JL, Cuevas-Mota J, Cerecer P, Moser K, Volker ML, Strathdee SA. PMID: 20409363; PMCID: PMC2953999.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    129. Tracing the origins of Mycobacterium bovis tuberculosis in humans in the USA to cattle in Mexico using spoligotyping. Int J Infect Dis. 2010 Sep; 14 Suppl 3:e129-35. Rodwell TC, Kapasi AJ, Moore M, Milian-Suazo F, Harris B, Guerrero LP, Moser K, Strathdee SA, Garfein RS. PMID: 20399697; PMCID: PMC2920372.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    130. Increased drug use and STI risk with injection drug use among HIV-seronegative heterosexual methamphetamine users. J Psychoactive Drugs. 2010 Mar; 42(1):11-8. Cheng WS, Garfein RS, Semple SJ, Strathdee SA, Zians JK, Patterson TL. PMID: 20464802; PMCID: PMC2907747.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    131. Ethical considerations in surveys employing respondent-driven sampling. Am J Public Health. 2010 Apr; 100(4):582-3; author reply 583-4. Semaan S, Heckathorn DD, Des Jarlais DC, Garfein RS. PMID: 20167881; PMCID: PMC2836345.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    132. HIV-tuberculosis coinfection in Southern California: evaluating disparities in disease burden. Am J Public Health. 2010 Apr 01; 100 Suppl 1:S178-85. Rodwell TC, Barnes RF, Moore M, Strathdee SA, Raich A, Moser KS, Garfein RS. PMID: 20147681; PMCID: PMC2837460.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansPHPublic Health
    133. Binge use and sex and drug use behaviors among HIV(-), heterosexual methamphetamine users in San Diego. Subst Use Misuse. 2010; 45(1-2):116-33. Cheng WS, Garfein RS, Semple SJ, Strathdee SA, Zians JK, Patterson TL. PMID: 20025442; PMCID: PMC2861916.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    134. Managing identity impacts associated with disclosure of HIV status: a qualitative investigation. AIDS Care. 2009 Aug; 21(8):1071-8. Frye V, Fortin P, MacKenzie S, Purcell D, Edwards LV, Mitchell SG, Valverde E, Garfein R, Metsch L, Latka MH. PMID: 20024764; PMCID: PMC3903159.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    135. Targeted screening and treatment for latent tuberculosis infection using QuantiFERON-TB Gold is cost-effective in Mexico. Int J Tuberc Lung Dis. 2009 Aug; 13(8):962-8. Burgos JL, Kahn JG, Strathdee SA, Valencia-Mendoza A, Bautista-Arredondo S, Laniado-Laborin R, Castañeda R, Deiss R, Garfein RS. PMID: 19723375; PMCID: PMC2763545.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansPHPublic Health
    136. Young adult injection drug users in the United States continue to practice HIV risk behaviors. Drug Alcohol Depend. 2009 Sep 01; 104(1-2):167-74. Rondinelli AJ, Ouellet LJ, Strathdee SA, Latka MH, Hudson SM, Hagan H, Garfein RS. PMID: 19559543.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    137. Influences of cross-border mobility on tuberculosis diagnoses and treatment interruption among injection drug users in Tijuana, Mexico. Am J Public Health. 2009 Aug; 99(8):1491-5. Deiss R, Garfein RS, Lozada R, Burgos JL, Brouwer KC, Moser KS, Zuniga ML, Rodwell TC, Ojeda VD, Strathdee SA. PMID: 19542040; PMCID: PMC2707467.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    138. Longitudinal determinants of consistent condom use by partner type among young injection drug users: the role of personal and partner characteristics. AIDS Behav. 2011 Oct; 15(7):1309-18. Kapadia F, Latka MH, Wu Y, Strathdee SA, Mackesy-Amiti ME, Hudson SM, Thiede H, Garfein RS. PMID: 19449099; PMCID: PMC3180628.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    139. The influence of needle exchange programs on injection risk behaviors and infection with hepatitis C virus among young injection drug users in select cities in the United States, 1994-2004. Prev Med. 2009 Aug; 49(1):68-73. Holtzman D, Barry V, Ouellet LJ, Des Jarlais DC, Vlahov D, Golub ET, Hudson SM, Garfein RS. PMID: 19410600.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    140. High prevalence of latent tuberculosis infection among injection drug users in Tijuana, Mexico. Int J Tuberc Lung Dis. 2009 May; 13(5):626-32. Garfein RS, Lozada R, Liu L, Laniado-Laborin R, Rodwell TC, Deiss R, Alvelais J, Catanzaro A, Chiles PG, Strathdee SA. PMID: 19383197; PMCID: PMC2744313.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    141. Cross-border paid plasma donation among injection drug users in two Mexico-U.S. border cities. Int J Drug Policy. 2009 Sep; 20(5):409-12. Volkow P, Brouwer KC, Loza O, Ramos R, Lozada R, Garfein RS, Magis-Rodriguez C, Firestone-Cruz M, Strathdee SA. PMID: 19230645; PMCID: PMC2955515.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    142. Differences in sexual risk behaviors among male and female HIV-seronegative heterosexual methamphetamine users. Am J Drug Alcohol Abuse. 2009; 35(5):295-300. Cheng WS, Garfein RS, Semple SJ, Strathdee SA, Zians JK, Patterson TL. PMID: 19591066; PMCID: PMC2913870.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    143. Tuberculosis and illicit drug use: review and update. Clin Infect Dis. 2009 Jan 01; 48(1):72-82. Deiss RG, Rodwell TC, Garfein RS. PMID: 19046064; PMCID: PMC3110742.
      View in: PubMed   Mentions: 80     Fields:    Translation:Humans
    144. Prevalence of hepatitis C virus infection among injection drug users in the United States, 1994-2004. Clin Infect Dis. 2008 Jun 15; 46(12):1852-8. Amon JJ, Garfein RS, Ahdieh-Grant L, Armstrong GL, Ouellet LJ, Latka MH, Vlahov D, Strathdee SA, Hudson SM, Kerndt P, Des Jarlais D, Williams IT. PMID: 18462109.
      View in: PubMed   Mentions: 86     Fields:    Translation:HumansCells
    145. A randomized intervention trial to reduce the lending of used injection equipment among injection drug users infected with hepatitis C. Am J Public Health. 2008 May; 98(5):853-61. Latka MH, Hagan H, Kapadia F, Golub ET, Bonner S, Campbell JV, Coady MH, Garfein RS, Pu M, Thomas DL, Thiel TK, Strathdee SA. PMID: 18382005; PMCID: PMC2374802.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    146. Ethical and regulatory considerations in HIV prevention studies employing respondent-driven sampling. Int J Drug Policy. 2009 Jan; 20(1):14-27. Semaan S, Santibanez S, Garfein RS, Heckathorn DD, Des Jarlais DC. PMID: 18243679.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    147. Mortality risk among recent-onset injection drug users in five U.S. cities. Subst Use Misuse. 2008; 43(3-4):413-28. Vlahov D, Wang C, Ompad D, Fuller CM, Caceres W, Ouellet L, Kerndt P, Jarlais DC, Garfein RS, Collaborative Injection Drug User Study. PMID: 18365941.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    148. The effect of intimate partner violence on receptive syringe sharing among young female injection drug users: an analysis of mediation effects. AIDS Behav. 2009 Apr; 13(2):217-24. Wagner KD, Hudson SM, Latka MH, Strathdee SA, Thiede H, Mackesy-Amiti ME, Garfein RS. PMID: 17876699; PMCID: PMC3690571.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    149. A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users. AIDS. 2007 Sep 12; 21(14):1923-32. Garfein RS, Golub ET, Greenberg AE, Hagan H, Hanson DL, Hudson SM, Kapadia F, Latka MH, Ouellet LJ, Purcell DW, Strathdee SA, Thiede H, DUIT Study Team. PMID: 17721100.
      View in: PubMed   Mentions: 82     Fields:    Translation:Humans
    150. Methods to recruit and retain a cohort of young-adult injection drug users for the Third Collaborative Injection Drug Users Study/Drug Users Intervention Trial (CIDUS III/DUIT). Drug Alcohol Depend. 2007 Nov; 91 Suppl 1:S4-17. Garfein RS, Swartzendruber A, Ouellet LJ, Kapadia F, Hudson SM, Thiede H, Strathdee SA, Williams IT, Bailey SL, Hagan H, Golub ET, Kerndt P, Hanson DL, Latka MH, DUIT Study Team. PMID: 17582705.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    151. Housing status and associated differences in HIV risk behaviors among young injection drug users (IDUs). AIDS Behav. 2007 Nov; 11(6):854-63. Coady MH, Latka MH, Thiede H, Golub ET, Ouellet L, Hudson SM, Kapadia F, Garfein RS. PMID: 17551825.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    152. Prevalence of hepatitis C virus and HIV infection among injection drug users in two Mexican cities bordering the U.S. Salud Publica Mex. 2007 May-Jun; 49(3):165-72. White EF, Garfein RS, Brouwer KC, Lozada R, Ramos R, Firestone-Cruz M, Pérez SG, Magis-Rodríguez C, Conde-Glez CJ, Strathdee SA. PMID: 17589770; PMCID: PMC2743977.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    153. Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004. J Urban Health. 2007 May; 84(3):436-54. Burt RD, Hagan H, Garfein RS, Sabin K, Weinbaum C, Thiede H. PMID: 17356901; PMCID: PMC2231834.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    154. Prevalence and correlates of indirect sharing practices among young adult injection drug users in five U.S. cities. Drug Alcohol Depend. 2007 Nov; 91 Suppl 1:S39-47. Thiede H, Hagan H, Campbell JV, Strathdee SA, Bailey SL, Hudson SM, Kapadia F, Garfein RS, DUIT Study Team. PMID: 17466464.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    155. Development, description, and acceptability of a small-group, behavioral intervention to prevent HIV and hepatitis C virus infections among young adult injection drug users. Drug Alcohol Depend. 2007 Nov; 91 Suppl 1:S73-80. Purcell DW, Garfein RS, Latka MH, Thiede H, Hudson S, Bonner S, Golub ET, Ouellet LJ, DUIT Study Team. PMID: 17466465.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    156. Perceived risk, peer influences, and injection partner type predict receptive syringe sharing among young adult injection drug users in five U.S. cities. Drug Alcohol Depend. 2007 Nov; 91 Suppl 1:S18-29. Bailey SL, Ouellet LJ, Mackesy-Amiti ME, Golub ET, Hagan H, Hudson SM, Latka MH, Gao W, Garfein RS, DUIT Study Team. PMID: 17434267.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    157. Distributive syringe sharing among young adult injection drug users in five U.S. cities. Drug Alcohol Depend. 2007 Nov; 91 Suppl 1:S30-8. Golub ET, Strathdee SA, Bailey SL, Hagan H, Latka MH, Hudson SM, Garfein RS, DUIT Study Team. PMID: 17398039.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    158. Injecting alone among young adult IDUs in five US cities: evidence of low rates of injection risk behavior. Drug Alcohol Depend. 2007 Nov; 91 Suppl 1:S48-55. Hagan H, Campbell JV, Thiede H, Strathdee SA, Ouellet L, Latka M, Hudson S, Garfein RS, DUIT Study Team. PMID: 17363193; PMCID: PMC2128771.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    159. Correlates of consistent condom use with main partners by partnership patterns among young adult male injection drug users from five US cities. Drug Alcohol Depend. 2007 Nov; 91 Suppl 1:S56-63. Kapadia F, Latka MH, Hudson SM, Golub ET, Campbell JV, Bailey S, Frye V, Garfein RS, DUIT Study Team. PMID: 17329041.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    160. Convenience is the key to hepatitis A and B vaccination uptake among young adult injection drug users. Drug Alcohol Depend. 2007 Nov; 91 Suppl 1:S64-72. Campbell JV, Garfein RS, Thiede H, Hagan H, Ouellet LJ, Golub ET, Hudson SM, Ompad DC, Weinbaum C, DUIT Study Team. PMID: 17276018.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansPHPublic Health
    161. Developing an HIV behavioral surveillance system for injecting drug users: the National HIV Behavioral Surveillance System. Public Health Rep. 2007; 122 Suppl 1:48-55. Lansky A, Abdul-Quader AS, Cribbin M, Hall T, Finlayson TJ, Garfein RS, Lin LS, Sullivan PS. PMID: 17354527; PMCID: PMC1804107.
      View in: PubMed   Mentions: 70     Fields:    Translation:HumansPHPublic Health
    162. Increasing syringe access and HIV prevention in California: findings from a survey of local health jurisdiction key personnel. J Urban Health. 2007 Jan; 84(1):116-25. Stopka TJ, Garfein RS, Ross A, Truax SR. PMID: 17151941; PMCID: PMC2078247.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    163. Design and feasibility of a randomized behavioral intervention to reduce distributive injection risk and improve health-care access among hepatitis C virus positive injection drug users: the Study to Reduce Intravenous Exposures (STRIVE). J Urban Health. 2007 Jan; 84(1):99-115. Kapadia F, Latka MH, Hagan H, Golub ET, Campbell JV, Coady MH, Garfein RS, Thomas DL, Bonner S, Thiel T, Strathdee SA. PMID: 17200799; PMCID: PMC2078252.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansPHPublic Health
    164. Self-reported hepatitis C virus antibody status and risk behavior in young injectors. Public Health Rep. 2006 Nov-Dec; 121(6):710-9. Hagan H, Campbell J, Thiede H, Strathdee S, Ouellet L, Kapadia F, Hudson S, Garfein RS. PMID: 17278406; PMCID: PMC1781913.
      View in: PubMed   Mentions: 83     Fields:    Translation:HumansCells
    165. Unprotected sexual behavior among heterosexual HIV-positive injection drug using men: associations by partner type and partner serostatus. J Urban Health. 2006 Jul; 83(4):656-68. Purcell DW, Mizuno Y, Metsch LR, Garfein R, Tobin K, Knight K, Latka MH. PMID: 16736116; PMCID: PMC2430482.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    166. Eligibility for treatment of hepatitis C virus infection among young injection drug users in 3 US cities. Clin Infect Dis. 2006 Mar 01; 42(5):669-72. Hagan H, Latka MH, Campbell JV, Golub ET, Garfein RS, Thomas DA, Kapadia F, Strathdee SA, Study to Reduce Intravenous Exposures Project Team. PMID: 16447112.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    167. Update and overview of practical epidemiologic aspects of HIV/AIDS among injection drug users in the United States. J Urban Health. 2006 Jan; 83(1):86-100. Santibanez SS, Garfein RS, Swartzendruber A, Purcell DW, Paxton LA, Greenberg AE. PMID: 16736357; PMCID: PMC2258331.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansPHPublic Health
    168. High prevalence of alcohol use among hepatitis C virus antibody positive injection drug users in three US cities. Drug Alcohol Depend. 2006 Feb 28; 81(3):259-65. Campbell JV, Hagan H, Latka MH, Garfein RS, Golub ET, Coady MH, Thomas DL, Strathdee SA, STRIVE Project. PMID: 16129567; PMCID: PMC2196223.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    169. Prevalence and correlates of chlamydia trachomatis, neisseria gonorrhoeae, trichomonas vaginalis infections, and bacterial vaginosis among a cohort of young injection drug users in Baltimore, Maryland. Sex Transm Dis. 2005 Jul; 32(7):446-53. Plitt SS, Garfein RS, Gaydos CA, Strathdee SA, Sherman SG, Taha TE. PMID: 15976603.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    170. Factors associated with interest in initiating treatment for hepatitis C Virus (HCV) infection among young HCV-infected injection drug users. Clin Infect Dis. 2005 Apr 15; 40 Suppl 5:S304-12. Strathdee SA, Latka M, Campbell J, O'Driscoll PT, Golub ET, Kapadia F, Pollini RA, Garfein RS, Thomas DL, Hagan H, Study to Reduce Intravenous Exposures Project. PMID: 15768339; PMCID: PMC2196220.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    171. Childhood sexual abuse and age at initiation of injection drug use. Am J Public Health. 2005 Apr; 95(4):703-9. Ompad DC, Ikeda RM, Shah N, Fuller CM, Bailey S, Morse E, Kerndt P, Maslow C, Wu Y, Vlahov D, Garfein R, Strathdee SA. PMID: 15798133; PMCID: PMC1449244.
      View in: PubMed   Mentions: 52     Fields:    Translation:Humans
    172. Prevalence and correlates of crack-cocaine injection among young injection drug users in the United States, 1997-1999. Drug Alcohol Depend. 2005 Mar 07; 77(3):227-33. Santibanez SS, Garfein RS, Swartzendruber A, Kerndt PR, Morse E, Ompad D, Strathdee S, Williams IT, Friedman SR, Ouellet LJ. PMID: 15734222.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    173. Changes in the sharing of drug injection equipment among street-recruited injection drug users in Chicago, Illinois, 1994--1996. Subst Use Misuse. 2005; 40(1):63-76. Huo D, Bailey SL, Garfein RS, Ouellet LJ. PMID: 15702649.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    174. Prevalence of cryoglobulinemia in hepatitis C virus (HCV) positive patients with and without human immunodeficiency virus (HIV) coinfection. J Clin Virol. 2004 Nov; 31(3):210-4. Dezzutti CS, Astemborski J, Thomas DL, Marshall JH, Cabrera T, Purdy M, Vlahov D, Garfein RS. PMID: 15465414.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    175. Factors associated with fulminant liver failure during an outbreak among injection drug users with acute hepatitis B. Hepatology. 2004 Oct; 40(4):865-73. Garfein RS, Bower WA, Loney CM, Hutin YJ, Xia GL, Jawanda J, Groom AV, Nainan OV, Murphy JS, Bell BP. PMID: 15382123.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCellsPHPublic Health
    176. Correlates of attempted suicide among young injection drug users in a multi-site cohort. Drug Alcohol Depend. 2004 Sep 06; 75(3):261-9. Havens JR, Strathdee SA, Fuller CM, Ikeda R, Friedman SR, Des Jarlais DC, Morse PS, Bailey S, Kerndt P, Garfein RS, Collaborative Injection Drug User Study Group. PMID: 15283947.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    177. Association between injection practices and duration of injection among recently initiated injection drug users. Drug Alcohol Depend. 2004 Aug 16; 75(2):177-83. Becker Buxton M, Vlahov D, Strathdee SA, Des Jarlais DC, Morse EV, Ouellet L, Kerndt P, Garfein RS. PMID: 15276223.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    178. Screening for depressive symptoms among HCV-infected injection drug users: examination of the utility of the CES-D and the Beck Depression Inventory. J Urban Health. 2004 Jun; 81(2):278-90. Golub ET, Latka M, Hagan H, Havens JR, Hudson SM, Kapadia F, Campbell JV, Garfein RS, Thomas DL, Strathdee SA, STRIVE Project. PMID: 15136661; PMCID: PMC3456451.
      View in: PubMed   Mentions: 50     Fields:    Translation:Humans
    179. Comparison of HIV infection risk behaviors among injection drug users from East and West Coast US cities. J Urban Health. 2004 Jun; 81(2):260-7. Garfein RS, Monterroso ER, Tong TC, Vlahov D, Des Jarlais DC, Selwyn P, Kerndt PR, Word C, Fernando MD, Ouellet LJ, Holmberg SD. PMID: 15136659; PMCID: PMC3456450.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    180. The use of needle exchange by young injection drug users. J Acquir Immune Defic Syndr. 2003 Sep 01; 34(1):67-70. Bailey SL, Huo D, Garfein RS, Ouellet LJ. PMID: 14501796.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansPHPublic Health
    181. HIV prevalence, risk behaviors, and high-risk sexual and injection networks among young women injectors who have sex with women. Am J Public Health. 2003 Jun; 93(6):902-6. Friedman SR, Ompad DC, Maslow C, Young R, Case P, Hudson SM, Diaz T, Morse E, Bailey S, Des Jarlais DC, Perlis T, Hollibaugh A, Garfein RS. PMID: 12773350; PMCID: PMC1447865.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansPHPublic Health
    182. Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City. Am J Epidemiol. 2003 Mar 01; 157(5):467-71. Des Jarlais DC, Diaz T, Perlis T, Vlahov D, Maslow C, Latka M, Rockwell R, Edwards V, Friedman SR, Monterroso E, Williams I, Garfein RS. PMID: 12615611.
      View in: PubMed   Mentions: 58     Fields:    Translation:Humans
    183. Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. Am J Epidemiol. 2002 Apr 01; 155(7):645-53. Thorpe LE, Ouellet LJ, Hershow R, Bailey SL, Williams IT, Williamson J, Monterroso ER, Garfein RS. PMID: 11914192.
      View in: PubMed   Mentions: 146     Fields:    Translation:HumansPHPublic Health
    184. Sexual orientation and HIV infection prevalence among young Latino injection drug users in Harlem. J Womens Health Gend Based Med. 2001 May; 10(4):371-80. Diaz T, Vlahov D, Greenberg B, Cuevas Y, Garfein R. PMID: 11445028.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    185. Factors associated with adolescent initiation of injection drug use. Public Health Rep. 2001; 116 Suppl 1:136-45. Fuller CM, Vlahov D, Arria AM, Ompad DC, Garfein R, Strathdee SA. PMID: 11889281; PMCID: PMC1913680.
      View in: PubMed   Mentions: 60     Fields:    Translation:HumansPHPublic Health
    186. Prevalence, incidence, and correlates of chlamydia and gonorrhea among young adult injection drug users. J Subst Abuse. 2001; 13(1-2):73-88. Latka M, Ahern J, Garfein RS, Ouellet L, Kerndt P, Morse P, Farshy CE, Des Jarlais DC, Vlahov D, Collaborative Injection Drug User Study Group. PMID: 11547626.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    187. Gender differences in the initiation of injection drug use among young adults. J Urban Health. 2000 Sep; 77(3):396-414. Doherty MC, Garfein RS, Monterroso E, Latkin C, Vlahov D. PMID: 10976613; PMCID: PMC3456045.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    188. The effect of a needle exchange program on numbers of discarded needles: a 2-year follow-up. Am J Public Health. 2000 Jun; 90(6):936-9. Doherty MC, Junge B, Rathouz P, Garfein RS, Riley E, Vlahov D. PMID: 10846512; PMCID: PMC1446248.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansPHPublic Health
    189. Correlates of HIV infection among young adult short-term injection drug users. AIDS. 2000 Apr 14; 14(6):717-26. Doherty MC, Garfein RS, Monterroso E, Brown D, Vlahov D. PMID: 10807195.
      View in: PubMed   Mentions: 82     Fields:    Translation:Humans
    190. Re: "High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: results of a cohort study". Am J Epidemiol. 1999 Aug 01; 150(3):325-6. Garfein RS, Lyerla R, Jones TS, Nakashima AK, Monterroso ER, Vlahov D. PMID: 10430240.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    191. Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. J Acquir Immune Defic Syndr Hum Retrovirol. 1998; 18 Suppl 1:S11-9. Garfein RS, Doherty MC, Monterroso ER, Thomas DL, Nelson KE, Vlahov D. PMID: 9663618.
      View in: PubMed   Mentions: 111     Fields:    Translation:Humans
    192. Discarded needles do not increase soon after the opening of a needle exchange program. Am J Epidemiol. 1997 Apr 15; 145(8):730-7. Doherty MC, Garfein RS, Vlahov D, Junge B, Rathouz PJ, Galai N, Anthony JC, Beilenson P. PMID: 9125999.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    193. Risk factors for human T-cell lymphotropic virus types I and II (HTLV-I and -II) in blood donors: the Retrovirus Epidemiology Donor Study. NHLBI Retrovirus Epidemiology Donor Study. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Mar 01; 14(3):263-71. Schreiber GB, Murphy EL, Horton JA, Wright DJ, Garfein R, Chien HC, Nass CC. PMID: 9117460.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    194. Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am J Public Health. 1996 May; 86(5):655-61. Garfein RS, Vlahov D, Galai N, Doherty MC, Nelson KE. PMID: 8629715; PMCID: PMC1380472.
      View in: PubMed   Mentions: 190     Fields:    Translation:Humans
    195. Physician satisfaction with human immunodeficiency virus type 1 and hepatitis B virus testing in San Diego County. Med Care. 1996 Jan; 34(1):1-10. Rau J, Cross JL, Hofherr LK, Peddecord KM, Benenson AS, Garfein RS, Francis DP. PMID: 8551808.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    196. Correlates of hepatitis C virus infections among injection drug users. Medicine (Baltimore). 1995 Jul; 74(4):212-20. Thomas DL, Vlahov D, Solomon L, Cohn S, Taylor E, Garfein R, Nelson KE. PMID: 7623656.
      View in: PubMed   Mentions: 108     Fields:    Translation:HumansCells
    197. Variability of reporting and lack of adherence to consensus guidelines in human T-lymphocyte immunophenotyping reports: results of a case series. J Acquir Immune Defic Syndr (1988). 1993 Jul; 6(7):823-30. Peddecord KM, Benenson AS, Hofherr LK, Francis DP, Garfein RS, Cross GD, Schalla WO. PMID: 8509982.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    198. Use of a physician survey to identify opportunities for quality improvement. Clin Lab Sci. 1993 Mar-Apr; 6(2):110-5. Peddecord KM, Hofherr LK, Benenson AS, Garfein RS, Francis DP, Cross JL, Rau J. PMID: 10171658.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    199. Physician experience with human immunodeficiency virus type 1 or hepatitis B virus testing in San Diego county: methods for a census survey. Clin Lab Sci. 1993 Mar-Apr; 6(2):102-9. Hofherr LK, Peddecord KM, Benenson AS, Garfein RS, Francis DP, Cross JL, Rau J, Hewitt DJ. PMID: 10148588.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    200. Use of a modified nominal group process for improving laboratory performance in human immunodeficiency virus type 1 antibody testing. Reaching consensus on three questions concerning HIV-1 testing. Clin Lab Manage Rev. 1992 Nov-Dec; 6(6):537-8, 543-6. Francis DP, Peddecord KM, Ferran KL, Benenson AS, Hofherr LK, Garfein RS, Schalla WO, Taylor RN. PMID: 10171690.
      View in: PubMed   Mentions: Translation:HumansCells
    201. Content and design of laboratory report forms for human immunodeficiency virus type 1 antibody testing. Am J Clin Pathol. 1992 Aug; 98(2):199-204. Hewitt DJ, Peddecord KM, Francis DP, Benenson AS, Hofherr LK, Ferran KL, Garfein RS, Gerber AR. PMID: 1510032.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    202. Identification of nonanalytic issues in HIV-1 antibody testing using blind proficiency testing. Clin Lab Sci. 1992 May-Jun; 5(3):172-6. Peddecord KM, Benenson AS, Hofherr LK, Garfein RS, Francis DP, Hewitt DJ, Ferran KL, Schalla WO, Hearn TL. PMID: 10147725.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    203. Analytic results of HIV-1 testing using blind proficiency testing. Clin Lab Sci. 1992 May-Jun; 5(3):165-71. Peddecord KM, Benenson AS, Hofherr LK, Francis DP, Garfein RS, Ferran KL, Taylor RN, Schalla WO, Ascher MS. PMID: 10147724.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    204. Methods for a model blind proficiency testing system. Clin Lab Sci. 1992 May-Jun; 5(3):160-4. Hofherr LK, Peddecord KM, Benenson AS, Garfein RS, Francis DP, Ferran KL, Taylor RN. PMID: 10147723.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    With one click, see people who:

    Mentor Faculty

    Run Clinical Trials

    See more options in the Advanced Search tab

    Richard's Networks
    Concepts (492)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (101)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSD Profiles is managed by the UC San Diego Altman Clinical and Translational Research Institute (ACTRI).
    This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California